Enzyme catalysed production of sialylated human milk oligosaccharides and galactooligosaccharides by Trypanosoma cruzi trans-sialidase

•Optimised reaction conditions for Trypanosoma cruzi trans-sialidase.•Quantitative production of 3′-sialyllactose from casein glycomacropeptide and lactose.•Enzymatic production of 3′-sialyl-lacto-N-tetraose.•Enzymatic production of doubly sialylated galactooligosaccharides.•Induced growth of select...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:New biotechnology 2014-03, Vol.31 (2), p.156-165
Hauptverfasser: Holck, Jesper, Larsen, Dorte M., Michalak, Malwina, Li, Haiying, Kjærulff, Louise, Kirpekar, Finn, Gotfredsen, Charlotte H., Forssten, Sofia, Ouwehand, Arthur C., Mikkelsen, Jørn D., Meyer, Anne S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Optimised reaction conditions for Trypanosoma cruzi trans-sialidase.•Quantitative production of 3′-sialyllactose from casein glycomacropeptide and lactose.•Enzymatic production of 3′-sialyl-lacto-N-tetraose.•Enzymatic production of doubly sialylated galactooligosaccharides.•Induced growth of selected Bifidobacterium strains by 3′-sialyllactose. A Trypanosoma cruzi trans-sialidase (E.C. 3.2.1.18) was cloned into Pichia pastoris and expressed. The pH and temperature optimum of the enzyme was determined as pH 5.7 and 30°C. Using casein glycomacropeptide (CGMP) and lactose as sialyl-donor and acceptor respectively, the optimal donor/acceptor ratio for the trans-sialidase catalysed 3′-sialyllactose production was found to be 1:4. Quantitative amounts of 3′-sialyllactose were produced from CGMP and lactose at a yield of 40mg/g CGMP. The 3′-sialyllactose obtained exerted a stimulatory effect on selected probiotic strains, including different Bifidobacterium strains in single culture fermentations. The trans-sialidase also catalysed the transfer of sialic acid from CGMP to galacto-oligosaccharides (GOS) and to the human milk oligosaccharide (HMO) backbone lacto-N-tetraose (LNT) to produce 3′-sialyl-GOS, including doubly sialylated GOS products, and 3′-sialyl-LNT, respectively. This work thus provides proof of the concept of producing 3′-sialyllactose and potentially other sialylated HMOs as well as sialylated GOS enzymatically by trans-sialidase activity, while at the same time providing valorisation of CGMP, a co-processing product from cheese manufacture.
ISSN:1871-6784
1876-4347
DOI:10.1016/j.nbt.2013.11.006